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Edited by Varda RotterAbstract In this study, we demonstrated that Ent-11a-hydroxy-
15-oxo-kaur-16-en-19-oic-acid (5F) had stronger cytotoxicity
against MKN-45, a gastric cancer cell line bearing wild-type
p53 than MKN-28, another gastric cancer cell line containing
missense mutation in p53. The rapid increase of ROS level was
involved in the mechanism of cytotoxicity. Classical features of
apoptosis induced by 5F were observed in MKN-45 cells only
or more signiﬁcant in MKN-45 cells than MKN-28 cells. Trans-
location of Bax from cytosol to mitochondria, reduction of Dwm
and DNA fragmentation were induced by 5F in the p53-depen-
dent manner. We conclude that the expression of Bax and its
downstream molecules requires the presentation of a wild-type
p53 in the cells treated by 5F.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Pteris semipinnata L. (PsL extract), a Chinese traditional
herb widely distributed in Southern China, is used to treat hep-
atitis, enteritis and snake bite [1]. The ethanolic extract of PsL
displays cytotoxic eﬀects on various cells and Ent-11a-hy-
droxy-15-oxo-kaur-16-en-19-oic-acid (5F), one of chemical
components isolated from PsL, has been known to have anti-
tumor activity [2–4]. One of the attractive strategies considered
in current cancer chemoprevention/chemotherapy is dietary or
pharmaceutical manipulation to induce death of malignant
cells through apoptosis. Recently, there are many evidences
showing that herbal medicines exert antitumoral activity by
inducing apoptosis in cancer cells [5–7].
Apoptosis is a fundamental form of cell death that plays a
major role in the development and homeostasis of multi-cellu-
lar organisms [8]. Many lines of evidence have indicated thatAbbreviations: ZVAD, benzyloxycarbonyl-Val-Ala-Asp-ﬂuorometh-
ylketone; DMSO, dimethyl sulfoxide; 5F, Ent-11a-hydroxy-15-oxo-
kaur-16-en-19-oic-acid; GSH, glutathione; PsL, Pteris semipinnata L.;
ROS, reactive oxygen species
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doi:10.1016/j.febslet.2005.01.050apoptotic process requires specialized machinery [9]. One of
the main regulatory steps of apoptotic cell death is controlled
by the ratio of anti-apoptotic (Bcl-2, Bcl-XL, Bag-1 and Bcl-
W) to pro-apoptotic (Bax, Bad, Bak and Bcl-Xs) members of
the Bcl-2 family [10,11]. Previous reports have demonstrated
that translocation of Bax to mitochondria can alter the perme-
ability of cytochrome c [12,13], which activates the post-mito-
chondrial caspases cascade (caspase-9 and -3) leading to
apoptotic cell death [11,14]. The translocation of Bax also al-
lows the release of apoptosis-inducing factor (AIF) from mito-
chondria. AIF is a caspase-independent apoptotic eﬀector,
which translocates via cytosol to nuclei, where it causes chro-
matin condensation and large scale DNA fragmentation, and
subsequently leads to apoptotic cell death [15].
Reactive oxygen species (ROS) are constantly generated un-
der normal condition as a consequence of aerobic metabolism.
Cells are equipped with an antioxidant defense system to com-
bat excessive production of ROS. Oxidative stress occurs in
cells when the generation of ROS overwhelms their natural
antioxidant defense. These excessive ROS can react with
DNA, proteins, carbohydrates and lipids in a destructive man-
ner [16]. There is a growing consensus that oxidative stress and
the redox state of a cell play a pivotal role in regulating apop-
tosis [17–19]. Oxidative stress induces a number of downstream
events in apoptosis, including caspase activation and DNA
fragmentation. The aim of the present study was to identify
the role of ROS formation on 5F-induced cell death in two
gastric cancer cell lines with diﬀerent p53 status.2. Materials and methods
2.1. Cell cuture
Two gastric cancer cell lines, MKN-45 bearing wild-type p53 and
MKN-28 containing missense mutation in p53 (codon 251, isoleucine
to leucine) [20], were cultured in RPMI 1640 containing 10% fetal bo-
vine serum, 100 U/ml penicillin, 100 lg/ml streptomycin at 37 C in
humidiﬁed atmosphere of 5% CO2/95% air. 5F, prepared as previous
description [2–4], was dissolved in dimethyl sulfoxide (DMSO) and di-
luted in cultured medium immediately before use (ﬁnal DMSO concen-
tration < 0.6%). In all the experiments, cells in RPMI 1640 medium
plus DMSO only were used as a control.
2.2. Assessment of cell death/viability and DNA fragmentation
MTT assay was used to quantify cell death/viability. DNA fragmen-
tation was determined by DNA fragmentation ELISA kit (Roche
Molecular Biochemicals, Mannheim, Germany). Brieﬂy, MKN-45
and MKN-28 cells were cultured to 80% conﬂuent and then exposedblished by Elsevier B.V. All rights reserved.
Fig. 1. Cytotoxicity of 5F in MKN-45 and MKN-28 cells. MKN-45 and MKN-28 cells were treated with various concentrations of 5F (0–150 mg/l)
for 24 h (A) or with 150 mg/l of 5F at indicated periods (B). The percentage of viability of treated cells was determined by MTT assay. In the
experiment of 5F cytotoxicity, the two gastric cancer cell lines were pretreated with 1 mM GSH or with 2 lM z-DEVD-fmk 1 or 2 h prior to the
treatment by 150 mg/l of 5F for 24 h (C).
Fig. 2. Eﬀect of 5F on DNA fragmentation in MKN-45 and MKN-28 cells. MKN-45 and MKN-28 cells were treated with various concentrations of
5F (0–150 mg/l) for 24 h (A) or with 150 mg/l of 5F at indicated periods (B). The DNA fragmentation was determined by cellular DNA
fragmentation ELISA assay. In the experiment using GSH and z-DEVE-fmk, the two gastric cancer cell lines were pretreated with 1 mM GSH or
with 2 lM z-DEVD-fmk 1 or 2 h prior to the treatment by 150 mg/l of 5F for 24 h (C).
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tathione (GSH), a ROS scavenger, and z-DEVD-fmk, a caspase-3
inhibitor, were given 1 or 2 h prior to the treatment with 5F.
2.3. Assessment of apoptosis and necrosis
The annexin V-ﬂuorescein kit (Molecular Probes, Eugene, OR) was
used to assay apoptosis and necrosis induced by 5F. Brieﬂy, the cells
(105) treated by 5F were harvested and washed with PBS, resuspended
with 100 ll of binding buﬀer (10 mM HEPES, 140 mM NaCl and
2.5 mM CaCl2, pH 7.4). Then, 5 ll of annexin V and 1 ll of propi-
dium iodide were added and incubated for 15 min in the dark. Bind-
ing buﬀer (400 ll) was then added to each tube and analyzed by ﬂow
cytometry.
2.4. Detection of ROS and Dwm by ﬂow cytometry
To evaluate intracellular ROS level, 5F-treated cells were incubated
with 10 lM CM-H2DCFDA (Molecular Probes, Eugene, OR) for
45 min at 37 C. To assess changes in DWm, 5F-treated cells were incu-
bated with 40 nM DiOD6 [3] (Sigma–Aldrich, St. Louis, MO) for
15 min at 37 C. Then cells were harvested by trypsin and washed with
PBS. Following resuspension in PBS, the cells were analyzed by ﬂow
cytometry at an excitation wavelength 488 nm and an emission wave-
length 525 nm.
2.5. Preparation of proteins in mitochondrial and cytosolic fraction
5F-treated cells were washed twice in ice-cold PBS and re-sus-
pended in 5 volumes of ice-cold extract buﬀer (20 mM HEPES-
KOH, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM DTTFig. 3. Apoptosis and necrosis in MKN-45 and MKN-28 cells treated with
indicated time. The percentages of viable, apoptotic and necrotic cells were
DEVE-fmk, the two gastric cancer cell lines were pretreated with 1 mM GSH
of 5F for 24 h. (A) MKN-45 cells; (B) MKN-28 cells. The results shown areand 0.1 mM PMSF, pH 7.5). The re-suspended cells were homoge-
nized with 10 strokes of Teﬂon homogenizer. The homogenates were
centrifuged twice at 750 · g for 10 min at 4 C. The supernatants
were centrifuged at 10 000 · g for 15 min at 4 C to obtain the mito-
chondrial pellets. Cytosolic fractions were obtained after further cen-
trifugation at 100 000 · g for 1 h at 4 C. The protein concentration
of the resulting supernatant and the mitochondrial fraction was mea-
sured and stored at 70 C.2.6. Western blotting analysis of Bax, cytochrome c, AIF, caspase-3 and
PARP
10 lg of protein from mitochondrial or cytosolic fractions for Bax,
cytochrome c, AIF assays and 50 lg of total protein from treated
cells for PARP, caspase-3 and b-actin assays were loaded onto
12% sodium dodecyl sulfate–polyacrylamide gels, and the separated
proteins were transferred to nitrocellulose membranes (Amersham
Biosciences, Piscataway, NJ). To detect the levels of Bax, cyto-
chrome c, AIF, a mouse-anti-human monoclonal Bax antibody
(BD Biosciences Clontech, Palo Alto, CA), a mouse-anti-human
monoclonal cytochrome c antibody (BioVision Research Products,
Mountain View, CA) and a mouse-anti-human monoclonal AIF
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) were em-
ployed in connection with a horseradish peroxidase-conjugated
goat-anti-mouse IgG antibody (Santa Cruz Biotechnology, Santa
Cruz, CA). Levels of caspase-3 and b-actin were analyzed using a
goat polyclonal caspase-3 antibody and a goat polyclonal b-actin
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) as the pri-
mary antibody, and a polyclonal mouse-anti-goat IgG antibody5F. MKN-45 and MKN-28 cells were treated with 150 mg/l of 5F at
determined by Annexin V kit. For the experiment using GSH and z-
or with 2 lM z-DEVD-fmk 1 or 2 h prior to the treatment by 150 mg/l
representative of three independent experiments.
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body. The levels of 85 kDa cleaved PARP were detected by using a
rabbit polyclonal PARP antibody (Promaga, Madison, WI) as the
primary antibody and a polyclonal goat-anti-rabbit IgG antibody
as the secondary antibody (Santa Cruz Biotechnology, Santa Cruz,
CA). The densities of the protein bands corresponding to the size
were determined and the relative amount of the target protein was
shown as Expression Index, which was calculated by the formula:
the density of the target band/the density of the control (b-actin)
band.Fig. 4. Generation of ROS in MKN-45 and MKN-28 cells treated with 5F.
After treatment, cells were stained with 10lM CM-H2DCFDA for 45 min at
of GSH on generation of ROS, the two gastric cancer cell lines were pretreate
(B). The horizontal axis shows the relative ﬂuorescence intensity and the vert
treatment; shaded peaks, 5F-treated cells. (B) Open peaks, 5F-treated cells; s
independent experiments.2.7. Measurement of caspase-3 activity
Caspase-3 activity was measured with a Colorimetric Assay Kit (As-
say Designs, Ann Arbor, MI). Brieﬂy, MKN-45 and MKN-28 cells
were cultured to 80% conﬂuent and treated with 5F at indicated con-
centrations and periods. GSH (Sigma, St. Louis, MO) and z-DEVD-
fmk (ALEXIS, Lausen, Switzerland) were given 1 or 2 h prior to the
treatment with 5F. After treatment cells were collected and lysed with
chilled lysis buﬀer (50 mM HEPES, 150 mM NaCl, 20 mM EDTA,
0.2% Triton X-100, 1 mM PMSF, 10 lg/ml aprotinin and 5 mM
DTT) for 10 min on ice. The lysates were centrifuged for 10 min atMKN-45 and MKN-28 cells were treated with 5F for 1, 3 or 6 h (A).
37 C and analyzed by ﬂow cytometry. In the experiment of inhibition
d with 1 mM GSH 1 h prior to the treatment by 150 mg/l of 5F for 1 h
ical axis shows cells number. (A) Open peaks, control cells without 5F-
haded peaks, 5F + GSH. The results shown are representative of three
Z. Liu et al. / FEBS Letters 579 (2005) 1477–1487 148110 000 · g, 4 C. The supernatant containing 100 lg of protein was
incubated with 0.2 mM of Ac-DEVD- pNA, a speciﬁc substrate for
caspase-3. The caspase-3 activity was measured at 405 nm with correc-
tion at 570 nm and expressed in Ac-pNA cleavage.
2.8. Statistical analysis
Data were expressed as means ± S.D. Diﬀerences between groups
were examined for statistical signiﬁcance using Students t test.
P < 0.05 was used to indicate a statistically signiﬁcant diﬀerence.3. Results
3.1. Cytotoxicity of 5F on MKN-45 and MKN-28 cells
Cytotoxicity of 5F on MKN-45 and MKN-28 cells was
examined. The viability of the cells treated with 5F was
determined by MTT. Compared with MKN-28 cells, the
viability of MKN-45 cells was more signiﬁcantly reduced
by 5F in time and concentration-dependent manners (Fig.
1A and B). It was observed that such a reduction could
be attenuated by GSH only in MKN-45 cells, but not in
MKN-28 cells. Surprisingly, z-DEVE-fmk, a caspase-3 inhib-
itor, did not attenuate the suppression of 5F on viability of
cells, but aggravated the suppression in these two cell lines
(Fig. 1C).3.2. DNA fragmentation in MKN-45 and MKN-28 cells treated
with 5F
To determine whether 5F can induce apoptosis, DNA frag-
mentation of MKN-45 and MKN-28 cells treated with 5F was
assessed with DNA fragmentation ELISA kit. The result
showed that DNA fragmentation was induced by 5F only in
MKN-45 cells, but not in MKN-28 cells and the induction
was in time and concentration-dependent manners (Fig. 2A
and B). Furthermore, the DNA fragmentation in MKN-45Fig. 5. Reduction of Dwm inMKN-45 and MKN-28 cells treated with 5F. MK
treatment, cells were stained with 40 nM DiOD6 [3] for 15 min at 37 C and a
Dwm, the two gastric cancer cell lines were pretreated with 1 mM GSH 1 h pr
MKN-28 cells. The horizontal axis shows the relative ﬂuorescence intensity, an
Dwm is indicated. The results shown are representative of three independenttreated with 5F was inhibited by GSH, but not by z-DEVE-
fmk (Fig. 2C). These results suggest that DNA fragmentation
induced by 5F is via a p53-dependent pathway, which is in-
volved in the formation of ROS.3.3. Apoptosis and necrosis in MKN-45 and MKN-28 cells
treated with 5F
To examine whether the cell death induced by 5F is apopto-
sis or necrosis, we assayed apoptotic and necrotic cell death in
MKN-45 and MKN-28 cells treated with 5F at indicated time
using annexin V and propidium iodide staining. The result
showed that apoptosis and necrosis were triggered after treat-
ment for 6 h. The apoptosis was topped at 12 h. After 12 h,
there was a shift from apoptosis to necrosis in MKN-45 cells,
but not in MKN-28 cells. GSH could attenuate apoptosis and
necrosis induced by 5F in MKN-45 cells (Fig. 3A), but not in
MKN-28 cells (Fig. 3B). However, necrosis can be induced in
MKN-28 cells by 5F after 12 h treatment.
3.4. Generation of ROS in MKN-45 and MKN-28 cells treated
with 5F
ROS generation in MKN-45 and MKN-28 cells treated with
5F was analyzed by ﬂow cytometry. The increase of ROS gen-
eration was observed in both MKN-45 and MKN-28 cells at
1 h following treatment with 5F (Fig. 4A). The elevation of
ROS level could be inhibited by GSH (Fig. 4B), conﬁrming
the involvement of ROS in the pathway of 5F.
3.5. Reduction of Dwm in MKN-45 and MKN-28 cells treated
with 5F
To examine whether 5F can induce the change of Dwm, we
measured Dwm in MKN-45 and MKN-28 cells treated with
5F. Following treatment with 5F, the change of Dwm was only
observed in MKN-45 cells (Fig. 5A), but not in MKN-28 cellsN-45 and MKN-28 cells were treated with 5F for 6, 12 and 24 h. After
nalyzed by ﬂow cytometry. In the experiment of GSH on reduction of
ior to the treatment by 150 mg/L of 5F for 24 h. (A) MKN-45 cells; (B)
d the vertical axis shows cells number. The percentage of cells with low
experiments.
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following treatment with 5F and the decrease was in a time-
dependent manner. Further, it was noted that the reduction
of Dwm could be attenuated by GSH (Fig. 5A). These results
indicated that the reduction of Dwm by 5F was associated with
the status of p53 and the generation of ROS.
3.6. Upregulation of Bax and translocation of Bax to
mitochondria in a p53-dependent manner
Translocation of Bax to mitochondria can alter the outer
mitochondrial membrane permeability. It allows the release
of pro-apoptotic proteins, such as cytochrome c and AIF
to cytosol. To test whether the apoptosis-inducing eﬀect ofFig. 6. Time course of Bax upregulation, Bax translocation to mitochondria,
PARP cleavage in MKN-45 cells. MKN-45 cells were treated with 150 mg/l o
mitochondrial fraction were extracted. The level of Bax, procaspase-3, and 85
in mitochondrial extract, and the levels of cytochrome c and AIF in cytosolic
bands were determined and the relative amount of the target protein was show
shown in B–G.5F was related to translocation of Bax to mitochondria, we
determined the level of Bax in total and mitochondrial pro-
teins of MKN-45 and MKN-28 cells by Western blot. As
shown in Fig. 6A and B, the total level of Bax was upregu-
lated in both MKN-45 and MKN-28 cells in a time-depen-
dent manner. However, the elevated level of total Bax was
much higher in MKN-45 cells than in MKN-28 cells. More-
over, the mitochondrial level of Bax was also found to be ele-
vated by 5F from 3 h in a time-dependent manner. However,
such an increase was observed only in MKN-45 cells but not
in MKN-28 cells (data for MKN-28 not shown). Therefore,
the expression of Bax and its translocation were diﬀerent be-
tween MKN-45 and MKN-28 cells after 5F treatment, sug-cytochrome c and AIF release from mitochondria, caspase-3 activation,
f 5F at indicated periods. After treatment, total protein, cytosolic and
kDa cleaved PARP fragment in total protein extract, the levels of Bax
extract, were analyzed by Western blot (A). The densities of the protein
n as Expression Index described in Section 2. The relevant results were
Z. Liu et al. / FEBS Letters 579 (2005) 1477–1487 1483gesting that the mechanism is p53-dependent in MKN-45
cells.
3.7. Release of cytochrome c and AIF from mitochondria to
cytosol
MKN-45 and MKN-28 cells were treated with 150 mg/L of
5F at indicated periods. The levels of cytochrome c and AIF
in cytosol were analyzed by Western blot. The results
showed that the levels of cytochrome c and AIF in cytosol
were signiﬁcantly elevated from 6 h in MKN-45 cells after
5F treatment, but not in MKN-28 cells (Figs. 6 and 7).
Therefore, the result indicated that after 5F treatment, the
release of cytochrome c and AIF from mitochondria to cyto-
sol postdated the translocation of Bax to mitochondria andFig. 7. Time course of Bax upregulation, Bax translocation to mitochondria,
PARP cleavage in MKN-28 cells. The culture and treatment of MKN-28 cell
of Bax, procaspase-3, and 85 kDa cleaved PARP fragment in total protein
cytochrome c and AIF in cytosolic extract, were analyzed by Western blot (A
amount of the target protein was shown as Expression Index described in Sboth events were associated with p53 status in the gastric
cancer cells tested.
3.8. Activation of caspase-3 and cleavage of PARP
MKN-45 and MKN-28 cells were treated with 150 mg/L of
5F at indicated periods. The levels of procaspase-3 and cleaved
PARP were analyzed by Western blot. The level of procaspase-
3 was decreased in both gastric cancer cell lines and the
reduction started at 6 h (Figs. 6 and 7). The reduction of pro-
caspase-3 is considered as a marker for the activation of cas-
pase-3. The caspase-3 activation by 5F in both types of the
cells was conﬁrmed by a signiﬁcant increase in caspase activity
(Fig. 8). Parallel to the activation of caspase-3, cleaved PARP
occurred at 6 h after treatment (Figs. 6 and 7). It was foundcytochrome c and AIF release from mitochondria, caspase-3 activation,
s were the same as MKN-45. Please refer to Fig. 6 for details. The level
extract, the levels of Bax in mitochondrial extract, and the levels of
). The densities of the protein bands were determined and the relative
ection 2. The relevant results were shown in B–F.
Fig. 8. Assessment of the activities of caspase-3 in 5F treated MKN-45 and MKN-28 cells. After MKN-45 and MKN-28 cells were treated with
150 mg/l at indicated periods they were collected and lysed. The caspase-3 activities of the lysates were measured with Colorimetric Assay Kit (A). In
order to determine the eﬀect of GSH and z-DEVD-fmk on caspase-3 activity, MKN-45 cells were pretreated with 1 mMGSH or with 2 lM z-DEVD-
fmk 1 or 2 h prior to the treatment by 150 mg/l of 5F for 24 h (B).
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cleaved PARP were much more signiﬁcant in MKN-45 cells
than in MKN-28 cells. Generally speaking, caspase-3 is mainly
activated through the release of cytochrome c from mitochon-
dria and activation of caspase-9. However, it is now known
that caspase-3 can also be activated by other molecules rather
than cytochrome c and caspase-9 [27,32,36].
3.9. Eﬀect of GSH and z-DEVE-fmk on upregulation of Bax,
translocation of Bax to mitochondria, release of cytochrome
c and AIF from mitochondria, activation of caspase-3,
cleavage of PARP in MKN-45 cells
To examine the eﬀect of ROS generation and the inhibition
of caspase-3 on the observed alterations of Bax, cytochrome c,
AIF, caspase-3 and PARP in MKN-45 cells, we treated the
cells with GSH 1 h prior to addition of 5F, or with z-DEVE-
fmk, a caspase-3 inhibitor, 2 h prior to treatment with 5F.
After treatment, the above molecules were analyzed by the
methods described previously. The result showed that the
upregulation of Bax, the translocation of Bax to mitochondria,
the release of cytochrome c and AIF from mitochondria, the
activation of caspase-3 and the cleavage of PARP, all of which
were caused by 5F treatment, were inhibited by GSH (Fig. 9),
suggesting that the apoptotic pathway mediated by 5F was
associated with the production of ROS in MKN-45 bearing
wild-type p53. However, the caspase-3 inhibitor, z-DEVE-
fmk, had no eﬀect on these alterations except inhibiting the
activation of caspase-3 and the cleavage of PARP, suggesting
that the observed alterations of Bax, cytochrome c and AIF
did not result from the activation of caspase-3 and cleavage
of PARP and that the activation of caspase-3 and cleavage
of PARP most likely occurred as the downstream event after
mitochondria in the pathway of 5F-induced apoptosis.4. Discussion
Using two gastric cancer cell lines, MKN-45 and MKN-28,
with diﬀerent status of p53, the present study demonstrates
that gastric cancer cells with wild-type p53 are much more sen-
sitive to the treatment by 5F, a chemical component isolatedfrom Chinese herbal medicine PsL, than those with mutant
p53. The importance of p53 in the treatment of gastric cancer
has also been shown in several other studies. Using the same
types of cells (MKN-45 and MKN-28), Jiang et al. [21] showed
that triptolide, a major component in the extract of Chinese
herbal plant TripterygiumWilfordii Hook f, induced apoptosis
in a p53-ependent pathway. Nagamine et al. [22] also reported
that troglitazone, a PPARc ligand, caused apoptosis through a
p53-dependent mechanism in MKN-45 cells. There is an
increasing evidence showing that the function of p53 is associ-
ated with the generation of ROS and that ROS may form a po-
sitive feedback signal to further stimulate p53 [23,24]. In the
present experiment, we found that 5F was able to stimulate
ROS production to a similar level in both MKN-45 and
MKN-28 cells irrespective of the status of p53, suggesting that
the generation of ROS is independent of p53 in the gastric can-
cer cells tested.
p53 can induce the expression of Bax, a pro-apoptotic gene
produce of Bcl-2 family. Bax has been proposed to control
mitochondrial membrane permeability either by forming a
channel in the outer mitochondrial membrane or by regulating
the opening and closing of the permeability transition pore
[25]. After the disruption of the membrane, mitochondrial pro-
teins including cytochrome c are released into the cytosol, acti-
vating caspase-9 and inhibiting anti-apoptotic proteins, which
leads to activation of downstream eﬀector caspases of apopto-
tic cascade [26]. In the present study, it appears that the expres-
sion of Bax can be inﬂuenced by the status of p53 as the level
of Bax can be signiﬁcantly elevated by 5F in MKN-45 cells
containing wild-type p53, compared with MKN-28 cells bear-
ing mutant p53. Similar to Bax, the reduction of Dwm, the re-
lease of mitochondrial proteins cytochrome c and AIF, and
DNA fragmentation are all recorded only in 5F-treated
MKN-45 cells but not in 5F-treated MKN-28 cells. We further
observed that the reduction of Dwm, the release of mitochon-
drial proteins cytochrome c and AIF, and DNA fragmentation
all occur after the level of Bax is stimulated by 5F and trans-
located into mitochondia. In consistence with these ﬁndings,
the activation of caspase-3, the cleavage of PARP and cytotox-
icity are much more signiﬁcant in MKN-45 cells than in
MKN-28 cells after 5F treatment. Therefore, the elevation of
Bax requires the presence of wild-type p53 to induce its down-
Fig. 9. Eﬀect of GSH and z-DEVE-fmk on upregulation of Bax, translocation of Bax to mitochondria, release of cytochrome c and AIF from
mitochondria, activation of caspase-3, cleavage of PARP in MKN-45 cells. MKN-45 cells were pretreated with GSH or with z-DEVD-fmk 1 or 2 h
prior to the treatment by 150 mg/l of 5F for 24 h. Total protein, cytosolic and mitochondrial fraction were extracted. The levels of Bax, procaspase-3,
and 85 kDa cleaved PARP fragment in total protein extract, the levels of Bax in mitochondrial extract, and the levels of cytochrome c and AIF in
cytosolic extract, were analyzed by Western blot (A). The densities of the protein bands were determined and the relative amount of the target protein
was shown as Expression Index described in Section 2. The relevant results were shown in B–G.
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ted by 5F.
ROS can be generated in many organelles in response to var-
ious stimuli. Major sources of ROS generation include the
mitochondria, endoplasmic reticulum, plasma membrane and
cytosol [16]. Though in our study 5F can induce the generation
of ROS in both p53 wild-type and p53 mutant gastric cancer
cells, ROS may not be able to execute its pro-apoptotic func-
tion in the gastric cancer cells bearing mutant p53. In the gas-
tric cancer cells bearing wild-type p53, all above pathologicalalterations caused by 5F can be rescued by GSH, but not by
DPI, an inhibitor of NADPH oxidase (data not shown). The
data support that the cell death-promoting eﬀect of 5F can
be blocked or attenuated by antioxidants.
One of the crucial intercellular signaling events in apoptosis
is the sequential activation of caspases, a family of cysteine
proteases [27–30]. Among the 14 isoforms of caspases de-
scribed to date, caspase-2, -8, -9, and 10 have long prodomains
that facilitate colocalization of these enzymes with interacting
adaptor proteins on apoptotic stimuli. Aggregation of these
1486 Z. Liu et al. / FEBS Letters 579 (2005) 1477–1487enzymes results in self-activation. The downstream eﬀector
caspases, such as caspase-3, -6, and -7, execute apoptotic re-
sponses by cleaving various cellular proteins [31]. Although,
caspases are important players in regulating apoptosis, their
function in cell death pathways is not indispensable, as
evidenced by the failure of pan-caspase inhibitors such as ben-
zyloxycarbonyl-Val-Ala-Asp-ﬂuoromethylketone (ZVAD) and
t-butyloxycarbonyl-Asp-ﬂuoromethylketone (Boc-D) to pre-
vent cell death in some cell death programs [27,28,32–35]. Sev-
eral apoptotic features such as normotonic cell shrinkage were
shown to be independent of caspase activation [36]. In many
cases, ZVAD completely blocks the nuclear events associated
with apoptosis but fails to prevent cell death [32–34]. Further-
more, the role of caspases, however, does not appear to be lim-
ited to apoptosis. Caspase-1 and caspase-11 are predominantly
involved in the process of inﬂammatory responses, and cas-
pase-4, -5, -12, -13 and -14, which are homologous to cas-
pase-1 in amino acid sequence, may also function as a
cytokine processor [37]. In our study, z-DEVE-fmk, a cas-
pase-3 inhibitor, can attenuate the activation of caspase-3
and the cleavage of PARP in 5F-treated gastric cancer cells,
but fails to inhibit DNA fragmentation and apoptotic cell
death. Moreover, necrotic cell death and cytotoxicity can be
aggravated by z-DEVE-fmk in 5F-treated gastric cancer cells.
Therefore, z-DEVE-fmk may possess nonspeciﬁc eﬀects other
than inhibition of caspase-3 and these nonspeciﬁc eﬀects ap-
pear to facilitate cell death induced by 5F in gastric cancer cells
examined in the present study.
In conclusion, 5F can induce cell death in gastric cancer cells
in a p53-dependent pathway, which is involved in the genera-
tion of ROS. The ROS appears to function as a molecule agent
at the upstream of p53. The failure of z-DEVE-fmk to prevent
cell death induced by 5F indicates that the activation of cas-
pase-3 is not critical in the cell death induced by 5F. There
should be other cell death pathways that can be activated when
caspase-3 pathway is inhibited.References
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